Revolution Medicines, Inc. (NASDAQ:RVMDW – Get Free Report)’s share price was up 2.9% during mid-day trading on Tuesday . The company traded as high as $6.08 and last traded at $6.01. Approximately 81,024 shares traded hands during trading, a decline of 45% from the average daily volume of 148,518 shares. The stock had previously closed at $5.84.
Revolution Medicines Trading Up 2.9%
The stock’s fifty day moving average price is $3.86 and its 200-day moving average price is $2.29.
About Revolution Medicines
Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.
Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.
Read More
- Five stocks we like better than Revolution Medicines
- Banks Are Buying Back Stock Hand Over Fist, Including These 3 Names
- 2 Aluminum Stocks Poised for Big Tariff-Related Gains
- AutoZone’s Pullback Sets Up a Long-Term Buying Opportunity
- AST SpaceMobile’s June Launch Plan Puts Its 2026 Satellite Goal Back in Focus
Receive News & Ratings for Revolution Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revolution Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
